Professor of Medicine, University Tex Houston
Gastroenterology
Dr. Robert S. Bresalier, MD
|
|
Give Review
Robert Bresalier works in the field of Gastroenterology. He studied medicine at University of Chicago Pritzker School of Medicine. University of Chicago Pritzker School of Medicine is ranked 10 in research and 19 in primary care medicine He has 4 awards "America's Top Doctors", "Top Doctors:SE Texas", "America's Top Doctors for Cancer" and "Men's Health". Robert S. Bresalier, MD is also published. He has 65 publications published. The lastest publication: "Outcome of Endoscopic Mucosal Resection As an Alternative to Surgery in Patients with Complex Colon Polyps.' Robert S. Bresalier is registered with Medicare and accepts Medicare payments.
Publications
- Outcome of Endoscopic Mucosal Resection As an Alternative to Surgery in Patients with Complex Colon Polyps.
- Urinary Metabolites of Prostanoids and Risk of Recurrent Colorectal Adenomas in the Aspirin/Folate Polyp Prevention Study (AFPPS).
- CRC Screening, Past, Present, and Future: A Tribute to Emmet Keeffe.
- Blood-Based Tests for Colorectal Cancer Screening: Do They Threaten the Survival of the FIT Test?
- Smoking-associated risks of conventional adenomas and serrated polyps in the colorectum.
- The association of age and race and the risk of large Bowel polyps.
- Genetic Variants in CYP2R1, CYP24A1, and VDR Modify the Efficacy of Vitamin D3 Supplementation for Increasing Serum 25-Hydroxyvitamin D Levels in a Randomized Controll...
- Adenoma detection in patients undergoing a comprehensive colonoscopy screening.
- CYP2C9 variants increase risk of Colorectal adenoma recurrence and modify associations with smoking but not aspirin treatment.
- Overexpressed galectin-3 in pancreatic Cancer induces cell proliferation and invasion by binding ras and activating ras signaling.
- Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy.
- Microsatellite instability and DNA mismatch repair protein deficiency in Lynch syndrome Colorectal polyps.
- Induction of MUC5AC mucin by conjugated bile acids in the Esophagus involves the phosphatidylinositol 3-kinase/protein kinase C/activator protein-1 pathway.
- Epidermal growth factor down-regulates the expression of neutrophil gelatinase-associated lipocalin (NGAL) through E-cadherin in pancreatic Cancer cells.
- A galectin-3 sequence polymorphism confers TRAIL sensitivity to human breast Cancer cells.
- Management of high-risk colonoscopy patients.
- The gastroIntestinal complications of oncologic therapy.
- Ability of integrated positron emission and computed tomography to detect significant colonic pathology: the experience of a tertiary Cancer center.
- A retrograde-viewing device improves detection of adenomas in the colon: a prospective efficacy evaluation (with videos).
- Antagonistic effects of aspirin and folic acid on inflammation markers and subsequent risk of recurrent Colorectal adenomas.
- Cyclooxygenase-2 polymorphisms, aspirin treatment, and risk for Colorectal adenoma recurrence--data from a randomized clinical trial.
- Using the results of a baseline and a surveillance colonoscopy to predict recurrent adenomas with high-risk characteristics.
- Global DNA hypomethylation (LINE-1) in the normal colon and lifestyle characteristics and dietary and genetic factors.
- Folic acid and risk of prostate Cancer: results from a randomized clinical trial.
- Nonsteroidal anti-inflammatory drug use after 3 years of aspirin use and Colorectal adenoma risk: observational follow-up of a randomized study.
- Galectin-3 mediates nuclear beta-catenin accumulation and Wnt signaling in human colon Cancer cells by regulation of glycogen synthase kinase-3beta activity.
- Polyphenon E inhibits the growth of human Barrett's and aeroDigestive adenocarcinoma cells by suppressing cyclin D1 expression.
- Barrett's Esophagus and esophageal adenocarcinoma.
- Cardiovascular events associated with rofecoxib: final analysis of the APPROVe trial.
- Colorectal adenomas in a randomized folate trial: the role of baseline dietary and circulating folate levels.
- Neutrophil gelatinase-associated lipocalin: a novel suppressor of invasion and angiogenesis in pancreatic Cancer.
- Chemoprevention of Colorectal cancer: why all the confusion?
- Adherence to the USDA Food Guide, DASH Eating Plan, and Mediterranean dietary pattern reduces risk of Colorectal adenoma.
- Phosphorylated galectin-3 mediates tumor necrosis factor-related apoptosis-inducing ligand signaling by regulating phosphatase and tensin homologue deleted on chromoso...
- Chemoprevention of Colorectal neoplasia: advances and controversies (the COX-2 story).
- Nucleotide excision repair gene polymorphisms and risk of advanced Colorectal adenoma: XPC polymorphisms modify smoking-related risk.
- Histologic subtypes as determinants of outcome in Esophageal carcinoma patients with pathologic complete response after preoperative chemoradiotherapy.
- Calcium plus vitamin D alters preneoplastic features of Colorectal adenomas and rectal mucosa.
- Phosphorylation of galectin-3 contributes to malignant transformation of human epithelial cells via modulation of unique sets of genes.
- The Editor's roundtable: cyclooxygenase-2 inhibitors and cardiovascular risk.
- Impact of cyclin D1 A870G polymorphism in Esophageal adenocarcinoma tumorigenesis.
- Galectin-3 modulates MUC2 mucin expression in human colon Cancer cells at the level of transcription via AP-1 activation.
- Value of baseline positron emission tomography for predicting overall survival in patient with nonmetastatic Esophageal or gastroEsophageal junction carcinoma.
- Colorectal cancer in patients under close colonoscopic surveillance.
- Diagnostic evaluation of patients with a high suspicion of malignancy: comorbidities and clinical predictors of Cancer.
- Bile acids induce MUC2 overexpression in human colon carcinoma cells.
- Hemochromatosis gene mutations and distal adenomatous Colorectal polyps.
- Calcium intake and Colorectal adenoma in a US Colorectal cancer early detection program.
- Treatment of Hereditary Colorectal Cancer Syndromes.
- Nuclear export of phosphorylated galectin-3 regulates its antiapoptotic activity in response to chemotherapeutic drugs.
- Dysplasia in Barrett Esophagus.
- Mucins and mucin binding proteins in Colorectal cancer.
- Alternative splicing of the human MUC2 gene.
- Clinical management of hereditary Colorectal cancer syndromes.
- Preface: Colorectal cancer.
- Aspirin and the prevention of Colorectal neoplasia.
- Predictors of advanced proximal neoplasia in persons with abnormal screening flexible sigmoidoscopy.
- Expression of human intestinal mucin is modulated by the beta-galactoside binding protein galectin-3 in colon Cancer.
- Intestinal mucin and Colorectal cancer: it's not just goo.
- Primary chemoprevention of familial adenomatous polyposis with sulindac: more questions than answers.
- Chemoprevention of Intestinal polyposis by COX-2 inhibition: from mouse to man.
- Alterations in Gastric mucin synthesis by Helicobacter pylori.
- Multiple Functional Risk Variants in a SMAD7 Enhancer Implicate a Colorectal Cancer Risk Haplotype.
- Calcium supplementation increases blood creatinine concentration in a randomized controlled trial.
Schools
U Of Chgo Div Of Bio Sci Pritzker Sch Of Med
Barnes Hospital Washington University
University Calif San Francisco
Procedures Preformed
- Colonoscopy, Proctosigmoidoscopy, and Sigmoidoscopy
- Endoscopy (Esophagus, Stomach, Small Intestine)
Conditions Treated
- Abdominal Pain
- Anemia
- Barrett's Esophagus
- Benign Neoplasm of the Digestive System
- View All
Doctors Specialties
- Gastroenterology
Accepted Insurances
Awards
- America's Top Doctors
- Top Doctors:SE Texas
- America's Top Doctors for Cancer
- Men's Health
Education
-
UCSF -
Washington University - Barnes-Jewish Hospital -
University of Chicago Pritzker School of Medicine
Hospital
-
University of Texas M.D. Anderson Cancer Center
Drug Facts
| NPI NUMBER | 1861586653 | |
| NPPES Provider LastName | BRESALIER | |
| NPPES Provider FirstName | ROBERT | |
| NPPES Provider ZIPCode | 770304009 | |
| NPPES Provider State | TX | |
| Specialty Description | Gastroenterology | |
| Total Claim Count | 94.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1861586653 |
| Last Name Of The Provider | BRESALIER |
| First Name Of The Provider | ROBERT |
| View All |
Similar Doctors
|
|
Dr. Walter L. Peterson, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Steven C. Ugbarugba, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Guru T. Reddy, MD |
|
Dr. Krishnamurthy Shivshanker, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Manoop Bhutani, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gagan K. Sood, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Kalpesh K. Patel, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. George E. Whalen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephen C. Pappas, MD |
|
Dr. Katherine Nguyen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ronald C. Colman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Susana Escalante-Glorsky, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Harsadbhai D. Patel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Akit Patel, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Norman B. Frankel, MD
This Doctor is OpenDoctor Recommended.
|